Literature DB >> 8831447

SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

V Molina Rodríguez1, R Montz Andreé, M J Pérez Castejón, E Capdevila García, J L Carreras Delgado, F J Rubia Vila.   

Abstract

OBJECTIVE: The purpose of this study was to find predictive criteria for response to clozapine.
METHOD: Single photon emission computed tomography studies of cerebral perfusion were done in 24 treatment-resistant schizophrenic patients while they were taking typical neuroleptics and again after they had been treated with clozapine for 6 months. Perfusion ratios of the subjects categorized as responders or nonresponders to clozapine and of the subjects in the two treatment conditions were compared. The ratios with significant between-group differences were compared to those from a normal database.
RESULTS: Before clozapine, while taking neuroleptics, subjects who became responders to clozapine showed higher thalamic, left basal ganglia, and right prefrontal perfusion. Nonresponders to clozapine had lower prefrontal perfusion and responders had higher subcortical perfusion than subjects in the normal database. The subcortical perfusion of the responders decreased when they received clozapine.
CONCLUSIONS: The study of cerebral perfusion may contribute to the prediction of response to clozapine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831447     DOI: 10.1176/ajp.153.10.1343

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 2.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 3.  Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.

Authors:  Shinichiro Nakajima; Hiroyoshi Takeuchi; Eric Plitman; Gagan Fervaha; Philip Gerretsen; Fernando Caravaggio; Jun Ku Chung; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Res       Date:  2015-02-13       Impact factor: 4.939

4.  Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophrenia.

Authors:  Felipe Ortuño; Miguel Moreno-Iñiguez; Manuel Millán; César A Soutullo; Raphael M Bonelli
Journal:  Wien Med Wochenschr       Date:  2006-04

Review 5.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

6.  Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T.

Authors:  Jun Hua; Allison S Brandt; SeungWook Lee; Nicholas I S Blair; Yuankui Wu; Su Lui; Jaymin Patel; Andreia V Faria; Issel Anne L Lim; Paul G Unschuld; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

7.  Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement.

Authors:  Vicente Molina; Juan D Gispert; Santiago Reig; Javier Sanz; Javier Pascau; Andrés Santos; Manuel Desco; Tomás Palomo
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

8.  Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Authors:  Anaïs Vandevelde; Lucie Métivier; Sonia Dollfus
Journal:  Can J Psychiatry       Date:  2020-11-02       Impact factor: 4.356

9.  Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool.

Authors:  Daniel G Amen; Manuel Trujillo; Andrew Newberg; Kristen Willeumier; Robert Tarzwell; Joseph C Wu; Barry Chaitin
Journal:  Open Neuroimag J       Date:  2011-07-28

Review 10.  Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.

Authors:  Elias Mouchlianitis; Robert McCutcheon; Oliver D Howes
Journal:  Lancet Psychiatry       Date:  2016-03-04       Impact factor: 27.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.